As of 2025-10-27, the EV/EBITDA ratio of Revolution Medicines Inc (RVMD) is -15.28. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. RVMD's latest enterprise value is 9,781.51 mil USD. RVMD's TTM EBITDA according to its financial statements is -639.94 mil USD. Dividing these 2 quantities gives us the above RVMD EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2025-10-16 | -13.88 |
| 2025-10-15 | -13.85 |
| 2025-10-14 | -13.25 |
| 2025-10-13 | -13.61 |
| 2025-10-10 | -13.46 |
| 2025-10-09 | -13.28 |
| 2025-10-08 | -13.34 |
| 2025-10-07 | -12.97 |
| 2025-10-06 | -12.98 |
| 2025-10-03 | -13.02 |
| 2025-10-02 | -12.72 |
| 2025-10-01 | -12.77 |
| 2025-09-30 | -13.01 |
| 2025-09-29 | -12.83 |
| 2025-09-26 | -12.20 |
| 2025-09-25 | -11.79 |
| 2025-09-24 | -12.09 |
| 2025-09-23 | -12.28 |
| 2025-09-22 | -12.34 |
| 2025-09-19 | -12.09 |
| 2025-09-18 | -12.58 |
| 2025-09-17 | -12.17 |
| 2025-09-16 | -12.43 |
| 2025-09-15 | -12.87 |
| 2025-09-12 | -12.97 |
| 2025-09-11 | -12.88 |
| 2025-09-10 | -11.19 |
| 2025-09-09 | -11.33 |
| 2025-09-08 | -11.36 |
| 2025-09-05 | -11.20 |
| 2025-09-04 | -10.75 |
| 2025-09-03 | -10.99 |
| 2025-09-02 | -10.92 |
| 2025-08-29 | -10.46 |
| 2025-08-28 | -10.57 |
| 2025-08-27 | -10.48 |
| 2025-08-26 | -10.26 |
| 2025-08-25 | -9.79 |
| 2025-08-22 | -10.18 |
| 2025-08-21 | -10.03 |
| 2025-08-20 | -9.93 |
| 2025-08-19 | -10.04 |
| 2025-08-18 | -10.02 |
| 2025-08-15 | -9.98 |
| 2025-08-14 | -9.89 |
| 2025-08-13 | -9.91 |
| 2025-08-12 | -9.67 |
| 2025-08-11 | -9.51 |
| 2025-08-08 | -9.59 |
| 2025-08-07 | -9.58 |